Table 4.
Comparison of infants with SBP ≥ or < 95th centile, within the BPD cohort.
| Variable | Infants with SBP ≥ 95 centile, n = 23 | Infants with SBP < 95 centile, n = 34 | P value |
|---|---|---|---|
| Gestational age (weeks)* | 26 (25, 27) | 27 (25, 28) | 0.049 |
| Birthweight (g)* | 786 (710, 990) | 700 (596, 858) | 0.28 |
| FGR | 6 (26) | 15 (44) | 0.26 |
| Umbilical artery catheter | 11 (48) | 24 (70) | 0.1 |
| Surfactant replacement therapy | 21 (91) | 30 (88) | 1 |
| PDA | 19 (83) | 27 (79) | 1 |
| PDA therapy | 18 (78) | 24 (70) | 0.55 |
| Use of postnatal steroids | 14 (61) | 18 (53) | 0.6 |
| Maternal diabetes | 4 (17) | 6 (17) | 1 |
| Pre-eclampsia | 8 (35) | 10 (29) | 0.8 |
| Chorioamnionitis | 5 (22) | 7 (20) | 0.2 |
| Duration of any respiratory support days, median (range) | 109 (81–138) | 87 (58–109) | < 0.001 |
Data presented as *median (interquartile range) or n (%), FGR Fetal growth restriction, PDA Patent ductus arteriosus, SBP Systolic blood pressure, BPD Bronchopulmonary dysplasia.